Free Trial
NYSE:NAVB

Navidea Biopharmaceuticals (NAVB) Stock Price, News & Analysis

Navidea Biopharmaceuticals logo
$0.0005 0.00 (0.00%)
As of 07/24/2025

About Navidea Biopharmaceuticals Stock (NYSE:NAVB)

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
N/A
52-Week Range
$0.00
$0.13
Volume
50 shs
Average Volume
8,460 shs
Market Capitalization
$50.04 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NAVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NAVB Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
SK Biopharmaceuticals Co. Ltd.
See More Headlines

NAVB Stock Analysis - Frequently Asked Questions

Navidea Biopharmaceuticals' stock was trading at $0.0001 at the start of the year. Since then, NAVB stock has increased by 400.0% and is now trading at $0.0005.

Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.03. The firm earned $0.10 million during the quarter, compared to analysts' expectations of $0.60 million.

Shares of NAVB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Navidea Biopharmaceuticals investors own include Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), CorMedix (CRMD), Sorrento Therapeutics (SRNE), Trevena (TRVN), Advanced Micro Devices (AMD) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/10/2021
Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NAVB
CIK
810509
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$8.13 thousand
Price / Sales
6.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
100,084,000
Free Float
56,367,000
Market Cap
$50.04 thousand
Optionable
Optionable
Beta
1.75
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:NAVB) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners